ANDA 74619, held by Barr Labs Inc. Glipizide.
As of Nov 16, 2026, ANDA 74619 (Glipizide), held by Barr Labs Inc, was first approved by FDA on Apr 4, 1997, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 4, 1997 | Original application | Approved | None posted |
| Aug 9, 2001 | Supplement 3Labeling | Approved | None posted |
| Jul 7, 2000 | Supplement 2Manufacturing | Approved | None posted |
| May 25, 2000 | Supplement 1Labeling | Approved | None posted |
| Apr 4, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters